Patents by Inventor Daisuke Doi

Daisuke Doi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12545894
    Abstract: The present invention provides a method for producing dopaminergic neuron progenitor cells from pluripotent stem cells, which method comprises the steps of: (i) performing adherent culture of pluripotent stem cells on an extracellular matrix in a medium containing a reagent(s) selected from the group consisting of BMP inhibitor, TGF? inhibitor, SHH signal-stimulating agent, FGF8, and GSK3? inhibitor; (ii) collecting Corin- and/or Lrtm1-positive cells from the cells obtained in Step (i) using a substance which binds to Corin and/or a substance which binds to Lrtm1; and (iii) performing suspension culture of the cells obtained in Step (ii) in a medium containing a neurotrophic factor.
    Type: Grant
    Filed: May 25, 2022
    Date of Patent: February 10, 2026
    Assignees: Kyoto University, Osaka University, Eisai R&D Management Co., Ltd.
    Inventors: Jun Takahashi, Daisuke Doi, Bumpei Samata, Kiyotoshi Sekiguchi, Yuichi Ono
  • Patent number: 12543929
    Abstract: A processor comprises a receiver including a recess. The recess includes a channel, and an inflatable body located in the channel. The inflatable body has an outer periphery surface and an inner periphery surface. The inner periphery surface defines a central opening in the inflatable body. The inflatable body is reversibly inflatable between a deflated state and an inflated state.
    Type: Grant
    Filed: April 17, 2023
    Date of Patent: February 10, 2026
    Assignee: Olympus Medical Systems Corp.
    Inventor: Daisuke Doi
  • Patent number: 12516286
    Abstract: A cell population comprising Corin- and/or Lrtm1-positive cells was produced by the following steps (1) and (2), from which Corin positive and/or Lrtm1 positive cells are collected using a substance that binds to Corin and/or a substance that binds to Lrtm1, and dopaminergic neuron progenitor cells are produced by performing suspension culture of the Corin positive and/or Lrtm1 positive cells in a culture solution containing one or more nutritional factors: (1) a step of performing adhesion culture of pluripotent stem cells in a medium for maintaining undifferentiated state containing a Sonic hedgehog (SHH) signal stimulant, and an undifferentiated state-maintaining factor in the absence of feeder cells but in the presence of an extracellular matrix, and (2) a step of culturing the cell population obtained in the step (1) in a culture solution containing one or more differentiation-inducing factors.
    Type: Grant
    Filed: December 14, 2023
    Date of Patent: January 6, 2026
    Assignees: KYOTO UNIVERSITY, RACTHERA Co., Ltd.
    Inventors: Jun Takahashi, Daisuke Doi, Kenji Yoshida, Atsushi Kuwahara, Masayo Takahashi
  • Patent number: 12347947
    Abstract: An antenna element includes a body including laminated insulator layers, a first ground conductor, and a radiation conductor overlapping the first ground conductor along a first direction from the first ground conductor. Guard ground conductors are provided in the body along the first direction to surround the radiation conductor. The guard ground conductors include second ground conductors electrically interconnected, and one or more first interlayer connection conductors piercing the insulator layers. The second ground conductors are shaped to not make a circuit of the radiation conductor, and are positioned at multiple positions relative to up-down directions.
    Type: Grant
    Filed: August 3, 2023
    Date of Patent: July 1, 2025
    Assignee: MURATA MANUFACTURING CO. , LTD.
    Inventors: Hirotaka Fujii, Koji Kamada, Daisuke Doi
  • Publication number: 20250145948
    Abstract: A method for assessing differentiation potential of cells in a culture broth in the differentiation of pluripotent stem cells into neural cells of the midbrain floor plate region, comprising: measuring a concentration of NT-3 in a culture supernatant in a culture broth obtained by culturing the pluripotent stem cells in a medium containing an inducer of differentiation into the neural cells of the midbrain floor plate region; comparing the measured concentration of NT-3 with a reference concentration; and when the concentration of NT-3 is equal to or more than the reference concentration, assessing the cells in the culture broth as capable of differentiating into the neural cells of the midbrain floor plate region, wherein the culture supernatant is a culture supernatant collected from the culture broth at any time from 48 hours to 240 hours after the start of culture of the pluripotent stem cells.
    Type: Application
    Filed: February 9, 2023
    Publication date: May 8, 2025
    Applicants: SUMITOMO PHARMA CO., LTD., KYOTO UNIVERSITY
    Inventors: ATSUSHI NAKANE, KENJI YOSHIDA, YUKA AOYAGI, MEGUMI IKEDA, JUN TAKAHASHI, DAISUKE DOI
  • Publication number: 20240279602
    Abstract: The present disclosure provides a cerebral organoid derived from a human pluripotent stem cell, a cell aggregate including a cerebral cortical cell, and a method for producing any of them, each being useful for regenerative therapy.
    Type: Application
    Filed: June 16, 2022
    Publication date: August 22, 2024
    Applicants: Kyoto University, Sumitomo Pharma Co., Ltd.
    Inventors: Jun TAKAHASHI, Daisuke DOI, Megumi IKEDA
  • Publication number: 20240117304
    Abstract: A cell population comprising Corin- and/or Lrtm1-positive cells was produced by the following steps (1) and (2), from which Corin positive and/or Lrtm1 positive cells are collected using a substance that binds to Corin and/or a substance that binds to Lrtm1, and dopaminergie neuron progenitor cells are produced by performing suspension culture of the Corin positive and/or Lrtm1 positive cells in a culture solution containing one or more nutritional factors: (1) a step of performing adhesion culture of pluripotent stem cells in a medium for maintaining undifferentiated state containing a Sonic hedgehog (SHH) signal stimulant, and an undifferentiated state-maintaining factor in the absence of feeder cells but in the presence of an extracellular matrix, and (2) a step of culturing the cell population obtained in the step (1) in a culture solution containing one or more differentiation-inducing factors.
    Type: Application
    Filed: December 14, 2023
    Publication date: April 11, 2024
    Applicants: KYOTO UNIVERSITY, SUMITOMO PHARMA CO., LTD.
    Inventors: Jun TAKAHASHI, Daisuke DOI, Kenji YOSHIDA, Atsushi KUWAHARA, Masayo TAKAHASHI
  • Patent number: 11898163
    Abstract: A cell population comprising Corin- and/or Lrtm1-positive cells was produced by the following steps (1) and (2), from which Corin positive and/or Lrtm1 positive cells are collected using a substance that binds to Corin and/or a substance that binds to Lrtm1, and dopaminergic neuron progenitor cells are produced by performing suspension culture of the Corin positive and/or Lrtm1 positive cells in a culture solution containing one or more nutritional factors: (1) a step of performing adhesion culture of pluripotent stem cells in a medium for maintaining undifferentiated state containing a Sonic hedgehog (SHH) signal stimulant, and an undifferentiated state-maintaining factor in the absence of feeder cells but in the presence of an extracellular matrix, and (2) a step of culturing the cell population obtained in the step (1) in a culture solution containing one or more differentiation-inducing factors.
    Type: Grant
    Filed: April 24, 2017
    Date of Patent: February 13, 2024
    Assignees: KYOTO UNIVERSITY, SUMITOMO PHARMA CO., LTD.
    Inventors: Jun Takahashi, Daisuke Doi, Kenji Yoshida, Atsushi Kuwahara, Masayo Takahashi
  • Publication number: 20230378651
    Abstract: An antenna element includes a body including laminated insulator layers, a first ground conductor, and a radiation conductor overlapping the first ground conductor along a first direction from the first ground conductor. Guard ground conductors are provided in the body along the first direction to surround the radiation conductor. The guard ground conductors include second ground conductors electrically interconnected, and one or more first interlayer connection conductors piercing the insulator layers. The second ground conductors are shaped to not make a circuit of the radiation conductor, and are positioned at multiple positions relative to up-down directions.
    Type: Application
    Filed: August 3, 2023
    Publication date: November 23, 2023
    Applicant: Murata Manufacturing Co., Ltd.
    Inventors: Hirotaka FUJII, Koji KAMADA, Daisuke DOI
  • Publication number: 20230337897
    Abstract: A processor comprises a receiver including a recess. The recess includes a channel, and an inflatable body located in the channel. The inflatable body has an outer periphery surface and an inner periphery surface. The inner periphery surface defines a central opening in the inflatable body. The inflatable body is reversibly inflatable between a deflated state and an inflated state.
    Type: Application
    Filed: April 17, 2023
    Publication date: October 26, 2023
    Applicant: OLYMPUS MEDICAL SYSTEMS CORP.
    Inventor: Daisuke DOI
  • Publication number: 20230301494
    Abstract: A medical apparatus comprises an insertion section inserted into a subject, a treatment instrument channel provided in the insertion section along an insertion axis extending from a proximal end to a distal end of the insertion section, a treatment instrument being inserted through the treatment instrument channel, an elastic member provided in at least a part of the treatment instrument channel, and a channel operation member for transmitting an operation force to the elastic member, and wherein the elastic member changes, according to the operation force, a sectional area of an inside of the treatment instrument channel in a direction crossing the insertion axis.
    Type: Application
    Filed: March 22, 2023
    Publication date: September 28, 2023
    Applicant: OLYMPUS MEDICAL SYSTEMS CORP.
    Inventor: Daisuke DOI
  • Publication number: 20230114089
    Abstract: The present invention provides a method for producing dopaminergic neuron progenitor cells from pluripotent stem cells, which method comprises the steps of: (i) performing adherent culture of pluripotent stem cells on an extracellular matrix in a medium containing a reagent(s) selected from the group consisting of BMP inhibitor, TGF? inhibitor, SHH signal-stimulating agent, FGF8, and GSK3? inhibitor; (ii) collecting Corin- and/or Lrtm1-positive cells from the cells obtained in Step (i) using a substance which binds to Corin and/or a substance which binds to Lrtm1; and (iii) performing suspension culture of the cells obtained in Step (ii) in a medium containing a neurotrophic factor.
    Type: Application
    Filed: May 25, 2022
    Publication date: April 13, 2023
    Applicants: KYOTO UNIVERSITY, OSAKA UNIVERSITY, EISAI R&D MANAGEMENT CO., LTD.
    Inventors: Jun Takahashi, Daisuke Doi, Bumpei Samata, Kiyotoshi Sekiguchi, Yuichi Ono
  • Publication number: 20230000071
    Abstract: Provided is a method for freezing a cell aggregate including neural cells. provided is a method for freezing a cell aggregate including neural cells and having a three-dimensional structure, which comprises following steps (1) and (2): (1) contacting a cell aggregate including neural cells and having a three-dimensional structure with a preservation solution at 0° C. to 30° C. prior to freezing to prepare a preservation solution-soaked cell aggregate; and (2) cooling the preservation solution-soaked cell aggregate obtained in step (1) from a temperature at least about 5° C. higher than the freezing point of the preservation solution to a temperature about 5° C. lower than the freezing point at an average cooling speed of 2 to 7° C./min to freeze the cell aggregate.
    Type: Application
    Filed: November 19, 2020
    Publication date: January 5, 2023
    Inventors: Satoe Hiramatsu, Takashi Nakagawa, Kenji Yoshida, Jun Takahashi, Daisuke Doi
  • Patent number: 11473058
    Abstract: The present invention provides a method for producing dopaminergic neuron progenitor cells from pluripotent stem cells, which method comprises the steps of: (i) performing adherent culture of pluripotent stem cells on an extracellular matrix in a medium containing a reagent(s) selected from the group consisting of BMP inhibitor, TGF? inhibitor, SHH signal-stimulating agent, FGF8, and GSK3? inhibitor; (ii) collecting Corin- and/or Lrtm1-positive cells from the cells obtained in Step (i) using a substance which binds to Corin and/or a substance which binds to Lrtm1; and (iii) performing suspension culture of the cells obtained in Step (ii) in a medium containing a neurotrophic factor.
    Type: Grant
    Filed: September 4, 2014
    Date of Patent: October 18, 2022
    Assignees: Kyoto University, Osaka University, Eisai R&D Management Co., Ltd.
    Inventors: Jun Takahashi, Daisuke Doi, Bumpei Samata, Kiyotoshi Sekiguchi, Yuichi Ono
  • Patent number: 11427806
    Abstract: The present invention provides a method for producing dopaminergic neuron progenitor cells from pluripotent stem cells, which method comprises the steps of: (i) performing adherent culture of pluripotent stem cells on an extracellular matrix in a medium containing a reagent(s) selected from the group consisting of BMP inhibitor, TGF? inhibitor, SHH signal-stimulating agent, FGF8, and GSK3? inhibitor; (ii) collecting Corin- and/or Lrtm1-positive cells from the cells obtained in Step (i) using a substance which binds to Corin and/or a substance which binds to Lrtm1; and (iii) performing suspension culture of the cells obtained in Step (ii) in a medium containing a neurotrophic factor.
    Type: Grant
    Filed: September 4, 2014
    Date of Patent: August 30, 2022
    Assignees: Kyoto University, Osaka University, Eisai R&D Management Co., Ltd.
    Inventors: Jun Takahashi, Daisuke Doi, Bumpei Samata, Kiyotoshi Sekiguchi, Yuichi Ono
  • Publication number: 20210162134
    Abstract: Provided is a microsyringe unit capable of improving the accuracy of the injection position of liquid in a brain. The microsyringe unit of the present invention is composed of a microsyringe (100) and a needle guide (200). The microsyringe (100) includes a cylindrical needle (110), a plunger (120) that is passed through the needle (110), and a needle base portion (130) that supports the needle (110). The needle base portion (130) abuts on a guide base portion (230) of the needle guide (200), thereby causing a part of the needle (110) to protrude from the tip of the needle guide (200) in a reference state in which forward movement of the needle (110) passed through the needle guide (200) is stopped.
    Type: Application
    Filed: July 26, 2019
    Publication date: June 3, 2021
    Inventors: Jun Takahashi, Daisuke Doi, Tetsuhiro Kikuchi, Ken Kato
  • Publication number: 20190112575
    Abstract: A cell population comprising Corin- and/or Lrtm1-positive cells was produced by the following steps (1) and (2), from which Corin positive and/or Lrtm1 positive cells are collected using a substance that binds to Corin and/or a substance that binds to Lrtm1, and dopaminergic neuron progenitor cells are produced by performing suspension culture of the Corin positive and/or Lrtm1 positive cells in a culture solution containing one or more nutritional factors: (1) a step of performing adhesion culture of pluripotent stem cells in a medium for maintaining undifferentiated state containing a Sonic hedgehog (SHH) signal stimulant, and an undifferentiated state-maintaining factor in the absence of feeder cells but in the presence of an extracellular matrix, and (2) a step of culturing the cell population obtained in the step (1) in a culture solution containing one or more differentiation-inducing factors.
    Type: Application
    Filed: April 24, 2017
    Publication date: April 18, 2019
    Applicants: KYOTO UNIVERSITY, SUMITOMO DAINIPPON PHARMA CO., LTD.
    Inventors: Jun TAKAHASHI, Daisuke DOI, Kenji YOSHIDA, Atsushi KUWAHARA, Masayo TAKAHASHI
  • Patent number: 9493620
    Abstract: Disclosed is an optical film that has excellent adhesion and surface hardness between the film substrate and a hard coat layer or other functional layer, has improved brittleness, is transparent, and has low moisture absorption and high heat resistance. Additionally disclosed are an antireflective film, a polarizing plate, and a display device using the same. The optical film has at least a hard coat layer or a back coat layer as a functional layer containing a resin on a film substrate, and is characterized in that said film substrate contains a thermoplastic acrylic resin (A) and a cellulose ester resin (B), with the content ratio by mass of said thermoplastic acrylic resin (A) and said cellulose ester resin (B) being in a range thermoplastic acrylic resin (A):cellulose ester resin (B)=95:5 to 50:50.
    Type: Grant
    Filed: August 10, 2009
    Date of Patent: November 15, 2016
    Assignee: KONICA MINOLTA OPTO, INC.
    Inventors: Satoshi Okano, Nobuo Kubo, Daisuke Doi
  • Patent number: 9453840
    Abstract: The present invention provides a method for selecting dopaminergic neuron progenitor cells, which comprises detecting any one or more of markers selected from the group consisting of CD15 (SSEA-1), CD24, CD46, CD47, CD49b, CD57, CD58, CD59, CD81, CD90, CD98, CD147, CD184, Disalogangliosid GD2, SSEA-4, CD49f, SERINC4, CCR9, PHEX, TMPRSS11E, HTR1E, SLC25A2, Ctxn3, Ccl7, Chrnb4, Chrna3, Kcnv2, Grm2, Syt2, Lim2, Mboat1, St3gal6, Slc39a12, Tacr1, Lrtm1, Dscam and CD201.
    Type: Grant
    Filed: July 27, 2012
    Date of Patent: September 27, 2016
    Assignees: Kyoto University, Eisai R&D Management Co., Ltd.
    Inventors: Jun Takahashi, Daisuke Doi, Bumpei Samata, Yuichi Ono
  • Publication number: 20160215260
    Abstract: The present invention provides a method for producing dopaminergic neuron progenitor cells from pluripotent stem cells, which method comprises the steps of: (i) performing adherent culture of pluripotent stem cells on an extracellular matrix in a medium containing a reagent(s) selected from the group consisting of BMP inhibitor, TGF? inhibitor, SHH signal-stimulating agent, FGF8, and GSK3? inhibitor; (ii) collecting Corin- and/or Lrtm1-positive cells from the cells obtained in Step (i) using a substance which binds to Corin and/or a substance which binds to Lrtm1; and (iii) performing suspension culture of the cells obtained in Step (ii) in a medium containing a neurotrophic factor.
    Type: Application
    Filed: September 4, 2014
    Publication date: July 28, 2016
    Inventors: Jun Takahashi, Daisuke Doi, Bumpei Samata, Kiyotoshi Sekiguchi, Yuichi Ono